查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1810910

2025年止血剂和组织密封胶全球市场报告

Hemostats And Tissue Sealants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年止血剂和组织密封胶市场将强劲成长，到2029年将达到56.1亿美元，复合年增长率为6.6%。预测期内的成长动力包括：门诊手术中心止血剂使用量的增加、对生物相容性和合成封闭剂的需求不断增长、外科创新和研发投资的不断扩大、术中血液管理意识的增强以及医疗保健支出的不断增长。预计在此期间的主要趋势包括：合成聚合物技术的进步、基于药物传递的封闭剂的创新、止血剂在微创手术中的应用、双功能封闭剂和止血剂的进步，以及生物工程和生物相容性材料的发展。

预计外科手术数量的增加将推动止血剂和组织密封胶市场的扩张。外科手术是指外科医师使用技术和器械进行的诊断、治疗或切除病变组织或器官，或恢復身体功能的程序。此类手术数量的增加主要是由于慢性疾病的盛行率上升，这些疾病通常需要外科手术介入才能妥善管理、治疗和预防併发症。止血剂和组织密封胶在这些手术中发挥关键作用，它们能够有效控制出血和封闭组织，从而最大限度地减少併发症并改善手术效果。例如，2024年6月，总部位于美国的整形外科专业组织国际美容外科学会 (ISAPS) 报告称，2023年全球外科手术数量增长了5.5%，达到1580多万例，非外科手术数量超过1910万例。这一趋势证实，外科手术数量的增加正在推动对止血剂和组织密封胶的需求。

止血和组织密封胶市场的主要企业正在优先开发创新产品，例如即用型可吸收胶原蛋白垫片，以提高外科手术的有效性和效率。这些基于胶原蛋白的止血钳采用生物活性、可吸收材料製成，无需准备，可立即用于有效的组织密封和止血。 2025 年 4 月，美国医疗保健公司百特国际在奥地利举行的研讨会上推出了其 Hemopatch Seal 止血钳。这款新产品设计用于室温储存，无需预热，可随时使用。它适用于开放性手术手术和微创手术，无需冷藏或额外准备。 Hemopatch 的强烈黏合强度、延长的保质期和快速的止血反应使手术期间能够更有效地控制出血和洩漏，有助于提高手术精度和各专业的患者预后。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球止血剂和组织密封胶：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球止血剂与组织密封胶市场：成长率分析
  • 全球止血剂与组织密封胶市场表现：规模与成长，2019-2024
  • 全球止血剂与组织密封胶市场预测：规模与成长，2024-2029 年，2034 年
  • 全球止血钳和组织密封胶市场：总目标市场（TAM）

第六章市场区隔

  • 全球止血剂及组织密封胶市场：依产品类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 局部止血剂
  • 黏合剂和组织密封胶
  • 纤维蛋白胶
  • 其他产品类型
  • 全球止血剂和组织密封胶市场：按成分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 基于生物学
  • 合成基底
  • 组合
  • 全球止血剂及组织密封胶市场：依通路、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 直销
  • 经销商
  • 网上销售
  • 全球止血剂和组织密封胶市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 外科手术
  • 创伤病例
  • 心血管外科
  • 一般外科
  • 其他用途
  • 全球止血剂和组织密封胶市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心（ASC）
  • 专科诊所
  • 研究和学术机构
  • 全球止血剂及组织密封胶市场：局部止血剂（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 机械式止血钳
  • 活性止血剂
  • 流体止血材料
  • 复合止血钳
  • 全球止血剂和组织密封胶市场：按黏合剂和组织密封胶（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 合成组织黏合剂
  • 组织组织黏合剂
  • 氰基丙烯酸酯黏合剂
  • 全球止血剂和组织密封胶市场：纤维蛋白胶细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 液体纤维蛋白胶
  • 贴片型纤维蛋白胶
  • 全球止血剂和组织密封胶市场：按产品类型细分、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 明胶基止血剂
  • 胶原蛋白基止血剂
  • 氧化再生纤维素止血材料

第七章 区域和国家分析

  • 全球止血剂与组织密封胶市场：区域分析、预测及展望（2019-2024 年、2024-2029 年、2034 年）
  • 全球止血剂及组织密封胶市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 止血剂与组织密封胶市场：竞争格局
  • 止血剂和组织密封胶市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Meril Life Sciences Pvt. Ltd.
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Corza Medical Inc.
  • Artivion Inc.
  • Ethicon Inc.
  • Advanced Medical Solutions Group plc
  • Marine Polymer Technologies Inc.
  • Samyang Holdings Corporation
  • 3-D Matrix Medical Technology Co Ltd.
  • GELITA AG
  • BioCer Entwicklungs-GmbH
  • AEGIS Lifesciences Pvt. Ltd.
  • Betatech Medical Ltd.
  • Cohera Medical Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年止血剂与组织密封胶市场：提供新机会的国家
  • 2029 年止血剂与组织密封胶市场：细分市场带来新机会
  • 2029 年止血剂与组织密封胶市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r37010

Hemostats and tissue sealants are products utilized during surgical procedures to manage bleeding (hemostasis) and seal tissues, thereby preventing the leakage of fluids like blood or air. Hemostats function by either encouraging clot formation or physically clamping blood vessels to halt bleeding, while tissue sealants are used to close wounds or surgical cuts, supporting quicker healing and lowering the likelihood of complications.

The primary categories of hemostats and tissue sealants include topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats are substances or materials directly applied to bleeding areas to control bleeding during surgeries or traumatic injuries. These are formulated from biological-based, synthetic-based, or combined materials, and are distributed through various channels such as direct sales, distributors, and online platforms. Their applications span across surgical procedures, trauma care, cardiovascular and general surgeries, among others, and they serve multiple end users including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The hemostats and tissue sealants market research report is one of a series of new reports from The Business Research Company that provides hemostats and tissue sealants market statistics, including hemostats and tissue sealants industry global market size, regional shares, competitors with a hemostats and tissue sealants market share, hemostats and tissue sealants market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats and tissue sealants industry. This hemostats and tissue sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats and tissue sealants market size has grown strongly in recent years. It will grow from $4.07 billion in 2024 to $4.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be credited to an expanding elderly population, a higher occurrence of trauma and accidents, a growing prevalence of cardiovascular diseases, increased investments in the medical field, and a rising preference for minimally invasive surgical procedures.

The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.61 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to the increasing use of hemostats in ambulatory surgical centers, rising demand for biocompatible and synthetic sealants, greater investments in surgical innovation and research and development, heightened awareness of blood management during surgeries, and growing healthcare spending. Key trends expected during this period include progress in synthetic polymer technologies, innovation in drug-delivery-based sealants, incorporation of hemostatic agents into minimally invasive procedures, advancements in dual-function sealants and hemostats, and the development of bioengineered and biocompatible materials.

The growing number of surgical procedures is expected to drive the expansion of the hemostats and tissue sealants market. Surgical procedures involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. The increase in these procedures is largely attributed to the rising prevalence of chronic diseases, which frequently require surgical intervention for proper management, treatment, or to prevent complications. Hemostats and tissue sealants play a crucial role in these procedures by effectively controlling bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. This trend underscores how the increasing number of surgical procedures is fueling the demand for hemostats and tissue sealants.

Leading companies in the hemostats and tissue sealants market are prioritizing the development of innovative products, such as ready-to-use absorbable collagen pads, to enhance the effectiveness and efficiency of surgical care. These collagen-based hemostats are designed using bioactive, resorbable materials that require no preparation, offering immediate application for effective tissue sealing and hemostasis. In April 2025, Baxter International Inc., a U.S.-based healthcare company, introduced the Hemopatch Sealing Hemostat at a symposium in Austria. This new product is designed for room temperature storage and offers the convenience of being ready-to-use without the need for pre-warming. It is suitable for both open and minimally invasive surgeries and eliminates the need for refrigeration or additional preparation. The Hemopatch's strong adhesive capabilities, extended shelf life, and rapid hemostatic response enable more efficient bleeding and leakage control during surgery, contributing to improved surgical precision and better patient recovery outcomes across various specialties.

In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. This acquisition is aimed at expanding Advanced Medical Solutions' surgical product portfolio, reinforcing its footprint in key European markets, and enhancing its position in the global wound care and closure technologies sector. Peters Surgical SAS, based in France, specializes in producing medical devices and instruments focused on hemostats and tissue sealants.

Major players in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., and Cohera Medical Inc.

North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in hemostats and tissue sealants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemostats and tissue sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats And Tissue Sealants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats and tissue sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats and tissue sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats and tissue sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Topical Hemostats; Adhesives And Tissue Sealants; Fibrin Sealants; Other Product Types
  • 2) By Composition: Biological Based; Synthetic Based; Combination
  • 3) By Distribution Channel: Direct Sales; Distributors; Online Sales
  • 4) By Application: Surgical Procedures; Trauma Cases; Cardiovascular Surgery; General Surgery; Other Applications
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centers (ASCs); Specialized Clinics; Research And Academic Institutes
  • Subsegments:
  • 1) By Topical Hemostats: Mechanical Hemostats; Active Hemostats; Flowable Hemostats; Combination Hemostats
  • 2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives; Biological Tissue Adhesives; Cyanoacrylate-Based Adhesives
  • 3) By Fibrin Sealants: Liquid Fibrin Sealants; Patch-Based Fibrin Sealants
  • 4) By Other Product Types: Gelatin-Based Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Becton, Dickinson and Company (BD); Stryker Corporation; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Teleflex Incorporated; Integra LifeSciences Holdings Corporation; Corza Medical Inc.; Artivion Inc.; Ethicon Inc.; Advanced Medical Solutions Group plc; Marine Polymer Technologies Inc.; Samyang Holdings Corporation; 3-D Matrix Medical Technology Co Ltd.; GELITA AG; BioCer Entwicklungs-GmbH; AEGIS Lifesciences Pvt. Ltd.; Betatech Medical Ltd.; Cohera Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostats And Tissue Sealants Market Characteristics

3. Hemostats And Tissue Sealants Market Trends And Strategies

4. Hemostats And Tissue Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hemostats And Tissue Sealants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemostats And Tissue Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemostats And Tissue Sealants Market Growth Rate Analysis
  • 5.4. Global Hemostats And Tissue Sealants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemostats And Tissue Sealants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemostats And Tissue Sealants Total Addressable Market (TAM)

6. Hemostats And Tissue Sealants Market Segmentation

  • 6.1. Global Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Hemostats
  • Adhesives And Tissue Sealants
  • Fibrin Sealants
  • Other Product Types
  • 6.2. Global Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biological Based
  • Synthetic Based
  • Combination
  • 6.3. Global Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Distributors
  • Online Sales
  • 6.4. Global Hemostats And Tissue Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Procedures
  • Trauma Cases
  • Cardiovascular Surgery
  • General Surgery
  • Other Applications
  • 6.5. Global Hemostats And Tissue Sealants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Clinics
  • Research And Academic Institutes
  • 6.6. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Topical Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Hemostats
  • Active Hemostats
  • Flowable Hemostats
  • Combination Hemostats
  • 6.7. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Adhesives And Tissue Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Tissue Adhesives
  • Biological Tissue Adhesives
  • Cyanoacrylate-Based Adhesives
  • 6.8. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Fibrin Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Fibrin Sealants
  • Patch-Based Fibrin Sealants
  • 6.9. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gelatin-Based Hemostats
  • Collagen-Based Hemostats
  • Oxidized Regenerated Cellulose-Based Hemostats

7. Hemostats And Tissue Sealants Market Regional And Country Analysis

  • 7.1. Global Hemostats And Tissue Sealants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemostats And Tissue Sealants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemostats And Tissue Sealants Market

  • 8.1. Asia-Pacific Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemostats And Tissue Sealants Market

  • 9.1. China Hemostats And Tissue Sealants Market Overview
  • 9.2. China Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemostats And Tissue Sealants Market

  • 10.1. India Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemostats And Tissue Sealants Market

  • 11.1. Japan Hemostats And Tissue Sealants Market Overview
  • 11.2. Japan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemostats And Tissue Sealants Market

  • 12.1. Australia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemostats And Tissue Sealants Market

  • 13.1. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemostats And Tissue Sealants Market

  • 14.1. South Korea Hemostats And Tissue Sealants Market Overview
  • 14.2. South Korea Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemostats And Tissue Sealants Market

  • 15.1. Western Europe Hemostats And Tissue Sealants Market Overview
  • 15.2. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemostats And Tissue Sealants Market

  • 16.1. UK Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemostats And Tissue Sealants Market

  • 17.1. Germany Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemostats And Tissue Sealants Market

  • 18.1. France Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemostats And Tissue Sealants Market

  • 19.1. Italy Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemostats And Tissue Sealants Market

  • 20.1. Spain Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemostats And Tissue Sealants Market

  • 21.1. Eastern Europe Hemostats And Tissue Sealants Market Overview
  • 21.2. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemostats And Tissue Sealants Market

  • 22.1. Russia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemostats And Tissue Sealants Market

  • 23.1. North America Hemostats And Tissue Sealants Market Overview
  • 23.2. North America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemostats And Tissue Sealants Market

  • 24.1. USA Hemostats And Tissue Sealants Market Overview
  • 24.2. USA Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemostats And Tissue Sealants Market

  • 25.1. Canada Hemostats And Tissue Sealants Market Overview
  • 25.2. Canada Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemostats And Tissue Sealants Market

  • 26.1. South America Hemostats And Tissue Sealants Market Overview
  • 26.2. South America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemostats And Tissue Sealants Market

  • 27.1. Brazil Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemostats And Tissue Sealants Market

  • 28.1. Middle East Hemostats And Tissue Sealants Market Overview
  • 28.2. Middle East Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemostats And Tissue Sealants Market

  • 29.1. Africa Hemostats And Tissue Sealants Market Overview
  • 29.2. Africa Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemostats And Tissue Sealants Market Competitive Landscape And Company Profiles

  • 30.1. Hemostats And Tissue Sealants Market Competitive Landscape
  • 30.2. Hemostats And Tissue Sealants Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hemostats And Tissue Sealants Market Other Major And Innovative Companies

  • 31.1. Meril Life Sciences Pvt. Ltd.
  • 31.2. Teleflex Incorporated
  • 31.3. Integra LifeSciences Holdings Corporation
  • 31.4. Corza Medical Inc.
  • 31.5. Artivion Inc.
  • 31.6. Ethicon Inc.
  • 31.7. Advanced Medical Solutions Group plc
  • 31.8. Marine Polymer Technologies Inc.
  • 31.9. Samyang Holdings Corporation
  • 31.10. 3-D Matrix Medical Technology Co Ltd.
  • 31.11. GELITA AG
  • 31.12. BioCer Entwicklungs-GmbH
  • 31.13. AEGIS Lifesciences Pvt. Ltd.
  • 31.14. Betatech Medical Ltd.
  • 31.15. Cohera Medical Inc

32. Global Hemostats And Tissue Sealants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostats And Tissue Sealants Market

34. Recent Developments In The Hemostats And Tissue Sealants Market

35. Hemostats And Tissue Sealants Market High Potential Countries, Segments and Strategies

  • 35.1 Hemostats And Tissue Sealants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemostats And Tissue Sealants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemostats And Tissue Sealants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer